Product Browser

Last updated: 2016/12/4

Product Compare

Product Compare Cancel Click this icon to add products to compare list. Select up to 10 products.

Quick Order (Tutorial)

Input Catalog #,
place order here!
Catalog # :
  • Where to buy
  • Choose your location

CHMP2A 293T Cell Transient Overexpression Lysate(Denatured)

  • Catalog # : H00027243-T03
  • Visit Frequency :
  • Countries :
  • Specification
  • Transfected Cell Line:
  • 293T
  • Plasmid:
  • pCMV-CHMP2A full-length
  • Host:
  • Human
  • Theoretical MW (kDa):
  • 24.42
  • Quality Control Testing:
  • Transient overexpression cell lysate was tested with Anti-CHMP2A antibody (H00027243-B01P) by Western Blots.
    SDS-PAGE Gel
    QC Testing of H00027243-T03
    CHMP2A transfected lysate.
    Western Blot
    QC Testing of H00027243-T03
    Lane 1: CHMP2A transfected lysate ( 24.42 KDa)
    Lane 2: Non-transfected lysate.
  • Storage Buffer:
  • 1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)
  • Storage Instruction:
  • Store at -80°C. Aliquot to avoid repeated freezing and thawing.
  • Applications
  • Western Blot
  • Application Image
  • Western Blot
  • Gene Information
  • Gene Name:
  • CHMP2A
  • Gene Alias:
  • BC-2,BC2,CHMP2,VPS2,VPS2A
  • Gene Description:
  • chromatin modifying protein 2A
  • Gene Summary:
  • CHMP2A belongs to the chromatin-modifying protein/charged multivesicular body protein (CHMP) family. These proteins are components of ESCRT-III (endosomal sorting complex required for transport III), a complex involved in degradation of surface receptor proteins and formation of endocytic multivesicular bodies (MVBs). Some CHMPs have both nuclear and cytoplasmic/vesicular distributions, and one such CHMP, CHMP1A (MIM 164010), is required for both MVB formation and regulation of cell cycle progression (Tsang et al., 2006 [PubMed 16730941]).[supplied by OMIM
  • Other Designations:
  • putative breast adenocarcinoma marker (32kD)
  • Gene Pathway
  • RSS
  • YouTube
  • Linkedin
  • Facebook